| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TRPM6 TEX14 PFKP CASK MB21D2 GUCY2C MAP3K10 EEF2K PRKDC TNKS2 MAPK9 ULK2 WNK2 MAP3K19 PRPS1 | 1.02e-04 | 938 | 104 | 15 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | TRPM6 TEX14 PFKP CASK GUCY2C MAP3K10 EEF2K PRKDC MAPK9 ULK2 WNK2 MAP3K19 PRPS1 | 1.68e-04 | 764 | 104 | 13 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | TRPM6 TEX14 CASK GUCY2C MAP3K10 EEF2K PRKDC MAPK9 ULK2 WNK2 MAP3K19 | 2.93e-04 | 600 | 104 | 11 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TRPM6 TEX14 PFKP CASK GUCY2C MAP3K10 EEF2K PRKDC MAPK9 ULK2 WNK2 MAP3K19 | 3.19e-04 | 709 | 104 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 5.39e-04 | 446 | 104 | 9 | GO:0004674 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 6.24e-04 | 363 | 104 | 8 | GO:0106310 | |
| GeneOntologyMolecularFunction | inositol bisphosphate phosphatase activity | 7.37e-04 | 8 | 104 | 2 | GO:0016312 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 1.07e-05 | 217 | 100 | 8 | GO:0000075 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 1.46e-05 | 163 | 100 | 7 | GO:0007093 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | 9.59e-05 | 219 | 100 | 7 | GO:1901991 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 9.93e-05 | 95 | 100 | 5 | GO:0030071 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly checkpoint signaling | 1.09e-04 | 51 | 100 | 4 | GO:0007094 | |
| GeneOntologyBiologicalProcess | spindle assembly checkpoint signaling | 1.09e-04 | 51 | 100 | 4 | GO:0071173 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 1.15e-04 | 98 | 100 | 5 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 1.27e-04 | 100 | 100 | 5 | GO:0007091 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic metaphase/anaphase transition | 1.27e-04 | 53 | 100 | 4 | GO:0045841 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid segregation | 1.27e-04 | 53 | 100 | 4 | GO:0033048 | |
| GeneOntologyBiologicalProcess | negative regulation of sister chromatid segregation | 1.27e-04 | 53 | 100 | 4 | GO:0033046 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid separation | 1.27e-04 | 53 | 100 | 4 | GO:2000816 | |
| GeneOntologyBiologicalProcess | mitotic spindle checkpoint signaling | 1.27e-04 | 53 | 100 | 4 | GO:0071174 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | 1.37e-04 | 311 | 100 | 8 | GO:1901988 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 1.46e-04 | 103 | 100 | 5 | GO:0044784 | |
| GeneOntologyBiologicalProcess | negative regulation of metaphase/anaphase transition of cell cycle | 1.47e-04 | 55 | 100 | 4 | GO:1902100 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome separation | 1.47e-04 | 55 | 100 | 4 | GO:1905819 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 1.48e-04 | 402 | 100 | 9 | GO:1901990 | |
| GeneOntologyBiologicalProcess | spindle checkpoint signaling | 1.69e-04 | 57 | 100 | 4 | GO:0031577 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome segregation | 1.69e-04 | 57 | 100 | 4 | GO:0051985 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 1.74e-04 | 107 | 100 | 5 | GO:2001251 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | KNTC1 DONSON INO80 TEX14 INTS3 USP44 SMARCA4 CDK5RAP2 TTI1 PRKDC | 2.03e-04 | 516 | 100 | 10 | GO:1901987 |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 2.06e-04 | 60 | 100 | 4 | GO:0033047 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 2.07e-04 | 111 | 100 | 5 | GO:0033045 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 2.31e-04 | 5 | 100 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic nuclear division | 2.64e-04 | 64 | 100 | 4 | GO:0045839 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid separation | 2.64e-04 | 64 | 100 | 4 | GO:0010965 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid separation | 3.15e-04 | 67 | 100 | 4 | GO:0051306 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 3.16e-04 | 266 | 100 | 7 | GO:0033044 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 3.81e-04 | 362 | 100 | 8 | GO:0010948 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | 4.25e-04 | 464 | 100 | 9 | GO:0045786 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear division | 4.38e-04 | 73 | 100 | 4 | GO:0051784 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | 4.49e-04 | 282 | 100 | 7 | GO:0045930 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 5.83e-04 | 139 | 100 | 5 | GO:0051983 | |
| GeneOntologyBiologicalProcess | regulation of chromosome separation | 5.91e-04 | 79 | 100 | 4 | GO:1905818 | |
| GeneOntologyBiologicalProcess | negative regulation of mitophagy | 6.39e-04 | 8 | 100 | 2 | GO:1901525 | |
| GeneOntologyBiologicalProcess | primitive erythrocyte differentiation | 6.39e-04 | 8 | 100 | 2 | GO:0060319 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy of mitochondrion | 6.39e-04 | 8 | 100 | 2 | GO:1903147 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 7.62e-04 | 37 | 100 | 3 | GO:0086005 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 8.24e-04 | 509 | 100 | 9 | GO:0044772 | |
| GeneOntologyBiologicalProcess | chromosome separation | 8.88e-04 | 88 | 100 | 4 | GO:0051304 | |
| HumanPheno | Decreased glucose-6-phosphate dehydrogenase level in blood | 3.35e-05 | 2 | 30 | 2 | HP:0410179 | |
| HumanPheno | Abnormal glucose-6-phosphate dehydrogenase level in blood | 3.35e-05 | 2 | 30 | 2 | HP:0410177 | |
| HumanPheno | Abnormal circulating glucose-6-phosphate dehydrogenase concentration | 3.35e-05 | 2 | 30 | 2 | HP:0410176 | |
| HumanPheno | Fava bean-induced hemolytic anemia | 1.00e-04 | 3 | 30 | 2 | HP:0004814 | |
| HumanPheno | Simplified gyral pattern | 1.11e-04 | 84 | 30 | 5 | HP:0009879 | |
| Domain | Kinase-like_dom | TRPM6 TEX14 CASK DST GUCY2C MAP3K10 EEF2K PRKDC MAPK9 ULK2 WNK2 MAP3K19 | 4.38e-05 | 542 | 103 | 12 | IPR011009 |
| Domain | Transcription_factor_COE | 1.79e-04 | 4 | 103 | 2 | IPR003523 | |
| Domain | COE_HLH | 1.79e-04 | 4 | 103 | 2 | IPR032201 | |
| Domain | COE_DBD | 1.79e-04 | 4 | 103 | 2 | IPR032200 | |
| Domain | TRPM_tetra | 1.79e-04 | 4 | 103 | 2 | IPR032415 | |
| Domain | Transcription_factor_COE_CS | 1.79e-04 | 4 | 103 | 2 | IPR018350 | |
| Domain | COE1_HLH | 1.79e-04 | 4 | 103 | 2 | PF16423 | |
| Domain | COE1_DBD | 1.79e-04 | 4 | 103 | 2 | PF16422 | |
| Domain | TRPM_tetra | 1.79e-04 | 4 | 103 | 2 | PF16519 | |
| Domain | COE | 1.79e-04 | 4 | 103 | 2 | PS01345 | |
| Domain | Alpha_kinase | 4.45e-04 | 6 | 103 | 2 | PF02816 | |
| Domain | ALPHA_KINASE | 4.45e-04 | 6 | 103 | 2 | PS51158 | |
| Domain | Alpha_kinase | 4.45e-04 | 6 | 103 | 2 | SM00811 | |
| Domain | MHCK_EF2_kinase | 4.45e-04 | 6 | 103 | 2 | IPR004166 | |
| Domain | ARM-type_fold | 5.78e-04 | 339 | 103 | 8 | IPR016024 | |
| Domain | - | 1.45e-03 | 222 | 103 | 6 | 1.25.10.10 | |
| Domain | Helicase_C | 2.91e-03 | 107 | 103 | 4 | PF00271 | |
| Domain | HELICc | 2.91e-03 | 107 | 103 | 4 | SM00490 | |
| Domain | Helicase_C | 3.01e-03 | 108 | 103 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 3.12e-03 | 109 | 103 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.12e-03 | 109 | 103 | 4 | PS51192 | |
| Domain | DEXDc | 3.12e-03 | 109 | 103 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.22e-03 | 110 | 103 | 4 | IPR014001 | |
| Domain | Ion_trans_dom | 3.66e-03 | 114 | 103 | 4 | IPR005821 | |
| Domain | Ion_trans | 3.66e-03 | 114 | 103 | 4 | PF00520 | |
| Domain | ARM-like | 3.83e-03 | 270 | 103 | 6 | IPR011989 | |
| Domain | Importin-beta_N | 3.88e-03 | 17 | 103 | 2 | IPR001494 | |
| Domain | Pkinase | 5.16e-03 | 381 | 103 | 7 | PF00069 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | IPO5 ZFYVE16 ARHGAP10 PFKP TDP2 KHSRP CASK MTMR7 XPO5 PRKDC RMND1 MAPK9 G6PD SNRNP200 PRPS1 | 2.45e-07 | 974 | 105 | 15 | 28675297 |
| Pubmed | IPO5 MYH10 NVL PFKP BIRC6 GTF3C3 KHSRP DST XPO5 SMARCA4 PRKDC SNRNP200 | 6.91e-07 | 653 | 105 | 12 | 22586326 | |
| Pubmed | IPO5 KNTC1 MYH10 COPS3 PFKP KHSRP EXOC5 THADA DST LDB1 XPO5 COMMD9 DHCR24 PRKDC G6PD SNRNP200 PRPS1 | 1.46e-06 | 1440 | 105 | 17 | 30833792 | |
| Pubmed | 1.47e-06 | 183 | 105 | 7 | 23956138 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | IPO5 HAUS7 COPS3 PFKP INTS3 EXOC5 XPO5 SMARCA4 PRKDC DDX39A SNRNP200 | 1.58e-06 | 582 | 105 | 11 | 20467437 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | EBF3 NVL COPS3 PFKP INTS3 GTF3C3 LDB1 SMARCA4 PRKDC DDX39A SNRNP200 | 1.61e-06 | 583 | 105 | 11 | 29844126 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYH10 EBF3 ARHGAP10 INTS3 GADD45GIP1 GTF3C3 KHSRP LDB1 CBFA2T2 SMARCA4 MAPK9 DDX39A SNRNP200 | 1.95e-06 | 857 | 105 | 13 | 25609649 |
| Pubmed | IPO5 BIRC6 EXOC5 THADA XPO5 DHCR24 SMARCA4 TTI1 PRKDC RMND1 SNRNP200 | 5.03e-06 | 657 | 105 | 11 | 36180527 | |
| Pubmed | Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A. | 5.17e-06 | 82 | 105 | 5 | 30274258 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | IPO5 MYH10 COPS3 PFKP RYR1 DST PRKDC DDX39A UNC79 G6PD SNRNP200 PRPS1 | 6.10e-06 | 807 | 105 | 12 | 30575818 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 7.91e-06 | 332 | 105 | 8 | 32786267 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25701119 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28236635 | ||
| Pubmed | Lateral Membrane-Specific MAGUK CASK Down-Regulates NaV1.5 Channel in Cardiac Myocytes. | 9.03e-06 | 2 | 105 | 2 | 27364017 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 15059886 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 15867147 | ||
| Pubmed | Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea. | 9.03e-06 | 2 | 105 | 2 | 18173836 | |
| Pubmed | IPO5 ENPP3 COPS3 PFKP SMARCA4 TTI1 PRKDC DDX39A SNRNP200 PRPS1 | 1.73e-05 | 613 | 105 | 10 | 22268729 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 1.86e-05 | 180 | 105 | 6 | 30110629 | |
| Pubmed | 1.96e-05 | 272 | 105 | 7 | 31010829 | ||
| Pubmed | 2.06e-05 | 497 | 105 | 9 | 23414517 | ||
| Pubmed | BIRC6 GTF3C3 CASK THADA DST CDK5RAP2 EEF2K PRKDC CLEC16A SNRNP200 PRPS1 | 2.39e-05 | 777 | 105 | 11 | 35844135 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 IPO5 KNTC1 MYH10 COPS3 GTF3C3 KHSRP THADA XPO5 DHCR24 SMARCA4 PRKDC G6PD SNRNP200 PRPS1 | 2.50e-05 | 1425 | 105 | 15 | 30948266 |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 26085571 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 20501672 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 17161064 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 9151732 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 18215251 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 16859949 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 29180353 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 19527720 | ||
| Pubmed | Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. | 2.70e-05 | 3 | 105 | 2 | 15314180 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 30832689 | ||
| Pubmed | 2.81e-05 | 396 | 105 | 8 | 26687479 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | IPO5 KNTC1 COPS3 PFKP BIRC6 KHSRP XPO5 TTI1 EEF2K PRKDC SEPTIN10 DDX39A G6PD SNRNP200 PRPS1 | 3.17e-05 | 1455 | 105 | 15 | 22863883 |
| Pubmed | 3.30e-05 | 120 | 105 | 5 | 27320910 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.56e-05 | 202 | 105 | 6 | 33005030 | |
| Pubmed | EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions. | 4.07e-05 | 63 | 105 | 4 | 29162697 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 20158304 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 9151733 | ||
| Pubmed | The diabetes susceptibility gene Clec16a regulates mitophagy. | 5.40e-05 | 4 | 105 | 2 | 24949970 | |
| Pubmed | Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis. | 5.40e-05 | 4 | 105 | 2 | 14765125 | |
| Pubmed | Involvement of DNA-dependent protein kinase in regulation of stress-induced JNK activation. | 5.40e-05 | 4 | 105 | 2 | 11749722 | |
| Pubmed | Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection. | 5.40e-05 | 4 | 105 | 2 | 12139918 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 36822331 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 24687990 | ||
| Pubmed | 6.89e-05 | 72 | 105 | 4 | 36376293 | ||
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 7.35e-05 | 142 | 105 | 5 | 19851296 | |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 7.60e-05 | 143 | 105 | 5 | 20198315 | |
| Pubmed | MYH10 ZFYVE16 ARHGAP10 CCDC18 BIRC6 CASK MTMR7 UBR3 CDK5RAP2 TTI1 MAPK9 G6PD | 7.91e-05 | 1049 | 105 | 12 | 27880917 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 15851119 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 23872634 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 12917357 | ||
| Pubmed | Stem cell niche-specific Ebf3 maintains the bone marrow cavity. | 8.97e-05 | 5 | 105 | 2 | 29563184 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 15261831 | ||
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 9.90e-05 | 79 | 105 | 4 | 26446488 | |
| Pubmed | 1.02e-04 | 30 | 105 | 3 | 30127719 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.09e-04 | 357 | 105 | 7 | 37059091 | |
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 23661717 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 22366412 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 11278395 | ||
| Pubmed | Alpha-kinases: a new class of protein kinases with a novel catalytic domain. | 1.34e-04 | 6 | 105 | 2 | 10021370 | |
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 20621716 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 17317669 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 9389446 | ||
| Pubmed | IPO5 ANK2 ZBTB47 TDP2 CASK ODF2L DST LDB1 SMARCA4 MAP3K10 PRKDC TNKS2 SNRNP200 | 1.34e-04 | 1285 | 105 | 13 | 35914814 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.38e-04 | 498 | 105 | 8 | 36634849 | |
| Pubmed | MYH10 ANK2 EBF3 KHSRP CASK DST LDB1 SMARCA4 CDK5RAP2 UNC79 WNK2 | 1.62e-04 | 963 | 105 | 11 | 28671696 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | IPO5 MYH10 COPS3 PFKP GTF3C3 KHSRP DST XPO5 PRKDC G6PD SNRNP200 PRPS1 | 1.85e-04 | 1149 | 105 | 12 | 35446349 |
| Pubmed | Defining human ERAD networks through an integrative mapping strategy. | 1.86e-04 | 173 | 105 | 5 | 22119785 | |
| Pubmed | 1.87e-04 | 390 | 105 | 7 | 17643375 | ||
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 1.88e-04 | 7 | 105 | 2 | 24786561 | |
| Pubmed | Endosomal sorting of Notch receptors through COMMD9-dependent pathways modulates Notch signaling. | 1.88e-04 | 7 | 105 | 2 | 26553930 | |
| Pubmed | JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate. | 1.88e-04 | 7 | 105 | 2 | 22753496 | |
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 15272007 | ||
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 19799863 | ||
| Pubmed | Requirement for protein synthesis during embryonic genome activation in mice. | 1.88e-04 | 7 | 105 | 2 | 9170106 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 1.90e-04 | 665 | 105 | 9 | 30457570 | |
| Pubmed | 1.93e-04 | 37 | 105 | 3 | 39305123 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | IPO5 KNTC1 HAUS7 COPS3 GTF3C3 ODF2L SMARCA4 CDK5RAP2 RNF41 PRKDC DDX39A SNRNP200 | 1.94e-04 | 1155 | 105 | 12 | 20360068 |
| Pubmed | 2.22e-04 | 282 | 105 | 6 | 23667531 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.26e-04 | 283 | 105 | 6 | 30585729 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 2.35e-04 | 182 | 105 | 5 | 31067453 | |
| Pubmed | TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation. | 2.50e-04 | 8 | 105 | 2 | 32179550 | |
| Pubmed | The JIP group of mitogen-activated protein kinase scaffold proteins. | 2.50e-04 | 8 | 105 | 2 | 10490659 | |
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 20810650 | ||
| Pubmed | Upstream distal regulatory elements contact the Lmo2 promoter in mouse erythroid cells. | 2.50e-04 | 8 | 105 | 2 | 23285212 | |
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 14993187 | ||
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 31884020 | ||
| Pubmed | 2.76e-04 | 103 | 105 | 4 | 10574462 | ||
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 2.86e-04 | 104 | 105 | 4 | 36055981 | |
| Pubmed | 3.02e-04 | 43 | 105 | 3 | 36950384 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 3.20e-04 | 564 | 105 | 8 | 21565611 | |
| Pubmed | Discovery of tissue-specific exons using comprehensive human exon microarrays. | 3.21e-04 | 9 | 105 | 2 | 17456239 | |
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 24657168 | ||
| Pubmed | Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex. | 3.21e-04 | 9 | 105 | 2 | 14504284 | |
| Pubmed | Fibroblast Growth Factor 21 Mediates Glycemic Regulation by Hepatic JNK. | 3.21e-04 | 9 | 105 | 2 | 26947074 | |
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 3.21e-04 | 9 | 105 | 2 | 17884088 | |
| Pubmed | 3.73e-04 | 437 | 105 | 7 | 20562859 | ||
| Pubmed | 3.77e-04 | 730 | 105 | 9 | 34857952 | ||
| Interaction | GPR17 interactions | 1.59e-06 | 283 | 101 | 10 | int:GPR17 | |
| Interaction | C3orf18 interactions | 1.81e-06 | 115 | 101 | 7 | int:C3orf18 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-07 | 186 | 105 | 7 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.10e-07 | 195 | 105 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PND01-03-samps-Epithelial-Epithelial-non_alveolar|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.71e-06 | 153 | 105 | 6 | fc0d2d50aa3b6b2772bbf3626c9df5c5e8d7d11e | |
| ToppCell | PND01-03-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.71e-06 | 153 | 105 | 6 | 2482247d9c39c7b99bb45fb9153442f64fd6012f | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.97e-06 | 177 | 105 | 6 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.97e-06 | 177 | 105 | 6 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.10e-06 | 178 | 105 | 6 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.10e-06 | 178 | 105 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.51e-06 | 181 | 105 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.96e-06 | 184 | 105 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.12e-06 | 185 | 105 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.12e-06 | 185 | 105 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.12e-06 | 185 | 105 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-06 | 186 | 105 | 6 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-06 | 186 | 105 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.28e-06 | 186 | 105 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.28e-06 | 186 | 105 | 6 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.28e-06 | 186 | 105 | 6 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.44e-06 | 187 | 105 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 5.61e-06 | 188 | 105 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.61e-06 | 188 | 105 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.61e-06 | 188 | 105 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.78e-06 | 189 | 105 | 6 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.78e-06 | 189 | 105 | 6 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 5.78e-06 | 189 | 105 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.78e-06 | 189 | 105 | 6 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 5.78e-06 | 189 | 105 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.78e-06 | 189 | 105 | 6 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 190 | 105 | 6 | e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.96e-06 | 190 | 105 | 6 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 190 | 105 | 6 | fe844559b95832845d2e8d3ab4b57e3d558bc372 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 5.96e-06 | 190 | 105 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-06 | 191 | 105 | 6 | acd844b477a069b2dcf07b2998e1b5c87dc0eb94 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-06 | 191 | 105 | 6 | e8d56e9f43943e9cc4dce83f2c234f19c2dd487d | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-06 | 191 | 105 | 6 | 52e8d7dfaf1ebb6df8bf3a1f4546af59faa67657 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.14e-06 | 191 | 105 | 6 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | ASK428-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.33e-06 | 192 | 105 | 6 | 356ebddd03aec341b79890977edb8ff0804999a1 | |
| ToppCell | CD8+_Memory_T_cell-RSV-5|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.33e-06 | 192 | 105 | 6 | 6357af0fb60a13a0ac727bc922b7606ab520ef5c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.72e-06 | 194 | 105 | 6 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 6.72e-06 | 194 | 105 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.92e-06 | 195 | 105 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | distal-Epithelial-Proximal_Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.92e-06 | 195 | 105 | 6 | abe7998421dc59bdae35c0c2251c4a1ebef5e021 | |
| ToppCell | distal-Epithelial-Proximal_Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.92e-06 | 195 | 105 | 6 | 0e3f74e0877d33c11f048b9be8394596cf5c9c4c | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.33e-06 | 197 | 105 | 6 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.55e-06 | 198 | 105 | 6 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.77e-06 | 199 | 105 | 6 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 | |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.77e-06 | 199 | 105 | 6 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 | |
| ToppCell | distal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.77e-06 | 199 | 105 | 6 | 7e5f29f4ec1fea92f2c0064eea151d2d474ef904 | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.77e-06 | 199 | 105 | 6 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.77e-06 | 199 | 105 | 6 | 2e8ace105c4e2405baa06d953e52888b54e2d055 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.99e-06 | 200 | 105 | 6 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.99e-06 | 200 | 105 | 6 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.99e-06 | 200 | 105 | 6 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.99e-06 | 200 | 105 | 6 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.99e-06 | 200 | 105 | 6 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.92e-06 | 118 | 105 | 5 | aefad0b35aff980b6a2a98057735442e8a65ab04 | |
| ToppCell | LPS-IL1RA-Unknown|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.92e-06 | 118 | 105 | 5 | 6cb4063b83f867b782080ce5b1199b51bb277f2a | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 125 | 105 | 5 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-05 | 129 | 105 | 5 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.34e-05 | 144 | 105 | 5 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-05 | 146 | 105 | 5 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.94e-05 | 151 | 105 | 5 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 154 | 105 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 154 | 105 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-05 | 155 | 105 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-05 | 155 | 105 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 159 | 105 | 5 | 00a157d033627d0e65c3fbd38d652c4cf56b47f6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.36e-05 | 164 | 105 | 5 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.36e-05 | 164 | 105 | 5 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-05 | 165 | 105 | 5 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-05 | 165 | 105 | 5 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.75e-05 | 167 | 105 | 5 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 169 | 105 | 5 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 169 | 105 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.17e-05 | 170 | 105 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.17e-05 | 170 | 105 | 5 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 5.46e-05 | 172 | 105 | 5 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-05 | 177 | 105 | 5 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-05 | 177 | 105 | 5 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-05 | 177 | 105 | 5 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-05 | 177 | 105 | 5 | 291231b1520c135e92739e201495fe1935efa927 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-05 | 177 | 105 | 5 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-05 | 180 | 105 | 5 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.95e-05 | 181 | 105 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.14e-05 | 182 | 105 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 7.14e-05 | 182 | 105 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 182 | 105 | 5 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.14e-05 | 182 | 105 | 5 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| Disease | Anemia, nonspherocytic hemolytic, due to G6PD deficiency | 1.21e-05 | 2 | 103 | 2 | cv:C2720289 | |
| Disease | ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY | 1.21e-05 | 2 | 103 | 2 | 300908 | |
| Disease | ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY | 1.21e-05 | 2 | 103 | 2 | C2720289 | |
| Disease | Metastatic melanoma | 3.87e-05 | 54 | 103 | 4 | C0278883 | |
| Disease | Brugada ECG Pattern | 7.21e-05 | 4 | 103 | 2 | C1721096 | |
| Disease | Brugada Syndrome (disorder) | 7.93e-05 | 24 | 103 | 3 | C1142166 | |
| Disease | sick sinus syndrome (is_implicated_in) | 1.20e-04 | 5 | 103 | 2 | DOID:13884 (is_implicated_in) | |
| Disease | long QT syndrome (is_implicated_in) | 2.51e-04 | 7 | 103 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | 10-undecenoate 11:1n1 measurement | 2.51e-04 | 7 | 103 | 2 | EFO_0021099 | |
| Disease | vitamin D deficiency | 2.94e-04 | 37 | 103 | 3 | EFO_0003762 | |
| Disease | Plasmodium falciparum malaria (is_implicated_in) | 3.33e-04 | 8 | 103 | 2 | DOID:14067 (is_implicated_in) | |
| Disease | sleep time | 5.33e-04 | 10 | 103 | 2 | EFO_0005274 | |
| Disease | antihyperlipidemic drug use measurement | 7.19e-04 | 115 | 103 | 4 | EFO_0803367 | |
| Disease | IGFBP-3 measurement | 9.00e-04 | 54 | 103 | 3 | EFO_0004626 | |
| Disease | COVID-19, coronary artery disease | 9.18e-04 | 13 | 103 | 2 | EFO_0001645, MONDO_0100096 | |
| Disease | Brugada Syndrome 1 | 9.18e-04 | 13 | 103 | 2 | C4551804 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.05e-03 | 57 | 103 | 3 | EFO_0022284 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 1.17e-03 | 59 | 103 | 3 | EFO_0022289 | |
| Disease | vitamin D measurement | 1.18e-03 | 336 | 103 | 6 | EFO_0004631 | |
| Disease | Romano-Ward Syndrome | 1.40e-03 | 16 | 103 | 2 | C0035828 | |
| Disease | response to methotrexate | 1.40e-03 | 16 | 103 | 2 | GO_0031427 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.41e-03 | 63 | 103 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.41e-03 | 63 | 103 | 3 | EFO_0022239 | |
| Disease | sphingomyelin 14:0 measurement | 1.59e-03 | 17 | 103 | 2 | EFO_0010390 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 1.78e-03 | 18 | 103 | 2 | OBA_2045175 | |
| Disease | neck circumference | 1.99e-03 | 19 | 103 | 2 | EFO_0011043 | |
| Disease | Brugada syndrome | 1.99e-03 | 19 | 103 | 2 | MONDO_0015263 | |
| Disease | iron biomarker measurement, ferritin measurement | 1.99e-03 | 19 | 103 | 2 | EFO_0004459, EFO_0004461 | |
| Disease | non-melanoma skin carcinoma | 2.41e-03 | 265 | 103 | 5 | EFO_0009260 | |
| Disease | stroke, coronary artery disease | 2.43e-03 | 21 | 103 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 2.43e-03 | 21 | 103 | 2 | EFO_0022246 | |
| Disease | tissue factor measurement | 2.43e-03 | 21 | 103 | 2 | EFO_0010623 | |
| Disease | amino acid measurement | 2.62e-03 | 678 | 103 | 8 | EFO_0005134 | |
| Disease | clinical and behavioural ideal cardiovascular health | 2.91e-03 | 23 | 103 | 2 | EFO_0007654 | |
| Disease | spermatogenic failure (is_implicated_in) | 2.91e-03 | 23 | 103 | 2 | DOID:0111910 (is_implicated_in) | |
| Disease | thyroxine measurement | 3.10e-03 | 83 | 103 | 3 | EFO_0005130 | |
| Disease | Colorectal Carcinoma | 3.23e-03 | 702 | 103 | 8 | C0009402 | |
| Disease | pancreatic carcinoma | 3.28e-03 | 174 | 103 | 4 | EFO_0002618 | |
| Disease | pulse pressure measurement | ABO ANK2 EBF1 INO80 CCDC141 ODF2L LDB1 TRPM3 CTNNA3 ANKRD11 UBR3 CLEC16A | 3.37e-03 | 1392 | 103 | 12 | EFO_0005763 |
| Disease | large artery stroke, coronary artery disease | 3.44e-03 | 25 | 103 | 2 | EFO_0001645, EFO_0005524 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QHVSLMTLDSIMKCA | 181 | Q8N1L4 | |
| MKTCLLMRQQHEAAA | 2601 | Q6UB99 | |
| EMQHMDVEESQCLRL | 1156 | Q9NR09 | |
| EVQRLTRACHQAMMV | 276 | P16442 | |
| AMLHNIDQEMLKCIE | 371 | Q9UNS2 | |
| MRCGLTEEKIAHQME | 171 | O43506 | |
| QEIFRLTPHEKQCMM | 211 | O00148 | |
| VRKNMGVCMQHDVLF | 1416 | Q86UK0 | |
| KLDSLMTLLRCQVHM | 416 | Q8IYW2 | |
| MTLLRCQVHMEMAQI | 421 | Q8IYW2 | |
| ICVISRQHMNTMIKA | 1266 | Q96SN8 | |
| TVVCFIVMRNKHMHT | 166 | Q9Y5X5 | |
| ESKNMNILIVLDMLC | 361 | Q9ULJ1 | |
| IRDVMQNHLLQMLCL | 256 | P11413 | |
| QNHLLQMLCLVAMEK | 261 | P11413 | |
| LMDHNRKSNVIIMCG | 236 | P25092 | |
| AQLQELVCHVMMGNL | 771 | Q68E01 | |
| AAMCAVNRVLMKLQE | 481 | O15381 | |
| MNLVMQFRKVCNHPE | 806 | Q9ULG1 | |
| CLTKINRMDIVHLME | 3636 | Q01484 | |
| VQRLLSMLMDVKTCN | 426 | A1A4S6 | |
| MHVMNCVSLVSDKEN | 1 | Q9C0D6 | |
| EILQMTVDHLKMLQA | 91 | Q9UBP5 | |
| LVMELMDANLCQVIH | 106 | P45984 | |
| MGITLKMNELNHCIV | 501 | O14936 | |
| KMNELNHCIVARIMH | 506 | O14936 | |
| LDMCQEMEQLLLHSQ | 186 | C9J442 | |
| MDIVERELHLLMCQL | 431 | Q02779 | |
| VLNITRLCMMSSHLK | 166 | O75121 | |
| QCNMLEHLSEETVML | 381 | Q8IYB1 | |
| CVILEPMQELMSRHK | 246 | Q86U70 | |
| CQLTDEQIHHLMKMI | 211 | Q8TAT5 | |
| ENQVMDNHMELVRLC | 101 | P46439 | |
| IHVMRNSLQKMLEVC | 276 | Q9Y216 | |
| ENINTMILLDKMHSC | 2641 | Q03001 | |
| LRKNVLTHCDQMVNM | 296 | O15327 | |
| FDNNIVKMCAHMSIV | 131 | Q9BQP9 | |
| LDHALNCIMEMVEKT | 351 | O43439 | |
| LAKNRMISLSECMIQ | 91 | Q8NGV7 | |
| HAVRLPLMECVQMTQ | 351 | Q01813 | |
| CDMLKIASMHSQQIR | 186 | Q8TDV5 | |
| VVVKMDNSRDLNMHC | 91 | A6NCN2 | |
| KHTLMAVELSRQCQM | 1156 | P50748 | |
| VHCLQDLEDMSVMVL | 171 | Q9ULW8 | |
| MLVQCMQDQEHPSIR | 176 | O00410 | |
| CLLLERMEEQVKNVM | 201 | Q96MC2 | |
| QAMCLEKIQRANELM | 31 | P41586 | |
| MKTLCSFLQISRNMH | 1 | Q8NGQ3 | |
| RMAVPTCLLQMKIQE | 141 | Q9P000 | |
| LILADMIDVMCLLQH | 136 | Q9UI47 | |
| IDRTLNCMIGQMKHI | 536 | O00471 | |
| MMGCIKRRVDHLTEQ | 431 | Q6ZP82 | |
| TMSMLQQDIICKQHH | 671 | Q5T9S5 | |
| MLMEGLKQRNLHNCV | 351 | O14638 | |
| VIEHCIQMSAMQNTK | 271 | A2CJ06 | |
| ALQKTMHEQMCLRQS | 551 | Q2WGN9 | |
| DMLVPMKCLQQALHT | 386 | Q15392 | |
| IQEMTKLGHELMLCA | 96 | Q99871 | |
| KNPEMCRVLLTHEIM | 146 | Q9UH73 | |
| ICLQMDKVLDMEVVH | 511 | Q9NYP3 | |
| EREQHIAECMAKMPQ | 116 | Q8TAE8 | |
| QVDIMQMCIIELKDR | 206 | O00418 | |
| EQSMVQMVCHLLECL | 2341 | Q9NYC9 | |
| KNPEMCRVLLTHEIM | 146 | Q9H4W6 | |
| IMRNMLSKLQIACDN | 71 | Q9H4P4 | |
| AVQCQEPLTMMALHI | 1626 | P21817 | |
| CVVHRDIKGNNVMLM | 1181 | Q56UN5 | |
| TVAQKLCHLLGMNVM | 376 | P35580 | |
| QTSELLQCLMVLMEK | 446 | Q6ZUA9 | |
| KVQQACEMVMDILRE | 291 | Q92945 | |
| ERNTLMVIKCLMENL | 886 | Q6YHU6 | |
| AMLEMLLQHQICKEV | 351 | Q99932 | |
| VEFMQRCASHMQAII | 141 | Q8IWB6 | |
| CVLDLKIMQTIMHEN | 736 | Q8IWB6 | |
| IMCHLESVKEIINEM | 731 | A6NFQ2 | |
| KILVHSLFNMLIMCT | 126 | Q14524 | |
| NHKVLLFCQMTSLMT | 1096 | P51532 | |
| VMNEKLQHCMELTDL | 401 | Q9NWS8 | |
| GLSMMQTLIHLLKCN | 41 | Q495N2 | |
| MATMENKVICALVLV | 1 | P04155 | |
| AMLLKVAMNRAQVCL | 561 | Q9Y5Q9 | |
| EHLMNSVMKLCVIIA | 671 | O75969 | |
| SLLDMSLVKLQLCHM | 36 | Q9BXL8 | |
| QQVLMSAGCIMKDVH | 571 | Q2KHT3 | |
| QHVSLMTLDSIMKCA | 181 | Q86W10 | |
| QSKHLFQILMECMVH | 361 | Q9BX84 | |
| LVTMKIMHDCVQLST | 271 | O14924 | |
| QTRQKALMALCDLMH | 41 | Q9UHP6 | |
| NIKMAHMLVAISVTC | 661 | Q6ZQN7 | |
| TQAQHLFIILMECMK | 431 | Q9HCF6 | |
| HLVDMELNCTVLQMD | 246 | P05543 | |
| ERHQMGCVSQMLIQK | 186 | Q86UE3 | |
| STKMMRNLLCVHVNV | 201 | O95551 | |
| IMNNMSLIIHRSCVE | 116 | P35504 | |
| NELLLTQMEKCALME | 636 | Q9HAV4 | |
| MLICTNMEDLREQTH | 301 | Q9P0V9 | |
| LEKHMNVTHSRMQIC | 451 | Q9UFB7 | |
| EKMMALLTPLNVNCH | 191 | Q9H2K2 | |
| LMTEVLCREQQHVME | 1761 | P78527 | |
| NVALMCMLREIGKHI | 511 | O75643 | |
| TLRHLNVMLMFTECV | 826 | Q8IYT8 | |
| ILMDHQNLSEHVLCM | 936 | Q6ZT12 | |
| MKHCSKIQVIDISMI | 281 | P60891 | |
| MVECQLETHNHKMVT | 1201 | Q9Y3S1 | |
| MLNIMVHASLLKYQC | 886 | Q6ZQQ6 | |
| MLAMDTCKHVGQLQL | 1 | Q9H0E7 | |
| NIDQLLIHMEMGKSC | 1241 | Q7Z3T8 | |
| QIAMDVMERCIHLLS | 861 | O43156 | |
| HNKVMVEMVCLHVIS | 2526 | Q9P2D8 | |
| TNMHLQLVRQEMAVC | 281 | Q7Z6G3 |